Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2002 3
2003 5
2004 6
2005 8
2006 3
2007 7
2008 7
2009 8
2010 5
2011 8
2012 17
2013 13
2014 13
2015 12
2016 24
2017 24
2018 31
2019 36
2020 16
Text availability
Article attribute
Article type
Publication date

Search Results

219 results
Results by year
Filters applied: . Clear all
Page 1
Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.
Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, Manshaei S, Jani N, Hölsken A, Pettorini B, Beynon RJ, Simpson DM, Fraser HC, Hong Y, Hallang S, Stone TJ, Virasami A, Donson AM, Jones D, Aquilina K, Spoudeas H, Joshi AR, Grundy R, Storer LCD, Korbonits M, Hilton DA, Tossell K, Thavaraj S, Ungless MA, Gil J, Buslei R, Hankinson T, Hargrave D, Goding C, Andoniadou CL, Brogan P, Jacques TS, Williams HJ, Martinez-Barbera JP. Apps JR, et al. Among authors: Hong Y. Acta Neuropathol. 2018 May;135(5):757-777. doi: 10.1007/s00401-018-1830-2. Epub 2018 Mar 14. Acta Neuropathol. 2018. PMID: 29541918 Free PMC article.
Transferrin receptor-involved HIF-1 signaling pathway in cervical cancer.
Xu X, Liu T, Wu J, Wang Y, Hong Y, Zhou H. Xu X, et al. Among authors: Hong Y. Cancer Gene Ther. 2019 Nov;26(11-12):356-365. doi: 10.1038/s41417-019-0078-x. Epub 2019 Jan 17. Cancer Gene Ther. 2019. PMID: 30651591
Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes.
DeFronzo RA, Hompesch M, Kasichayanula S, Liu X, Hong Y, Pfister M, Morrow LA, Leslie BR, Boulton DW, Ching A, LaCreta FP, Griffen SC. DeFronzo RA, et al. Among authors: Hong Y. Diabetes Care. 2013 Oct;36(10):3169-76. doi: 10.2337/dc13-0387. Epub 2013 Jun 4. Diabetes Care. 2013. PMID: 23735727 Free PMC article. Clinical Trial.
The Ubiquitin E3 Ligase TRAF6 Exacerbates Ischemic Stroke by Ubiquitinating and Activating Rac1.
Li T, Qin JJ, Yang X, Ji YX, Guo F, Cheng WL, Wu X, Gong FH, Hong Y, Zhu XY, Gong J, Wang Z, Huang Z, She ZG, Li H. Li T, et al. Among authors: Hong Y. J Neurosci. 2017 Dec 13;37(50):12123-12140. doi: 10.1523/JNEUROSCI.1751-17.2017. Epub 2017 Nov 7. J Neurosci. 2017. PMID: 29114077 Free PMC article.
Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO).
Li CY, Wang LX, Dong SS, Hong Y, Zhou XH, Zheng WW, Zheng C. Li CY, et al. Among authors: Hong Y. Med Sci Monit Basic Res. 2018 Jan 8;24:1-9. doi: 10.12659/msmbr.907775. Med Sci Monit Basic Res. 2018. PMID: 29307883 Free PMC article.
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial.
Zhu FC, Hu SY, Hong Y, Hu YM, Zhang X, Zhang YJ, Pan QJ, Zhang WH, Zhao FH, Zhang CF, Yang X, Yu JX, Zhu J, Zhu Y, Chen F, Zhang Q, Wang H, Wang C, Bi J, Xue S, Shen L, Zhang YS, He Y, Tang H, Karkada N, Suryakiran P, Bi D, Struyf F. Zhu FC, et al. Among authors: Hong Y. Cancer Med. 2019 Oct;8(14):6195-6211. doi: 10.1002/cam4.2399. Epub 2019 Jul 15. Cancer Med. 2019. PMID: 31305011 Free PMC article.
Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1.
Standing AS, Malinova D, Hong Y, Record J, Moulding D, Blundell MP, Nowak K, Jones H, Omoyinmi E, Gilmour KC, Medlar A, Stanescu H, Kleta R, Anderson G, Nanthapisal S, Gomes SM, Klein N, Eleftheriou D, Thrasher AJ, Brogan PA. Standing AS, et al. Among authors: Hong Y. J Exp Med. 2017 Jan;214(1):59-71. doi: 10.1084/jem.20161228. Epub 2016 Dec 19. J Exp Med. 2017. PMID: 27994071 Free PMC article.
Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation.
Mulhern CM, Hong Y, Omoyinmi E, Jacques TS, D'Arco F, Hemingway C, Brogan PA, Eleftheriou D. Mulhern CM, et al. Among authors: Hong Y. J Allergy Clin Immunol. 2019 Sep;144(3):863-866.e5. doi: 10.1016/j.jaci.2019.05.026. Epub 2019 Jun 5. J Allergy Clin Immunol. 2019. PMID: 31175876 Free PMC article. No abstract available.
219 results
Jump to page
Feedback